DE602005026407D1 - Materialien und verfahren zur stimulierung des immunsystems - Google Patents

Materialien und verfahren zur stimulierung des immunsystems

Info

Publication number
DE602005026407D1
DE602005026407D1 DE602005026407T DE602005026407T DE602005026407D1 DE 602005026407 D1 DE602005026407 D1 DE 602005026407D1 DE 602005026407 T DE602005026407 T DE 602005026407T DE 602005026407 T DE602005026407 T DE 602005026407T DE 602005026407 D1 DE602005026407 D1 DE 602005026407D1
Authority
DE
Germany
Prior art keywords
immune response
compound
antigen
stimulating
subject
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE602005026407T
Other languages
English (en)
Inventor
Raveendran P K Nair
Steven J Melnick
Cheppail Ramachandran
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
VARIETY CHILDREN S HOSPITAL dba MIAMI CHILDREN S HOSPITAL MIAMI
Original Assignee
VARIETY CHILDREN S HOSPITAL dba MIAMI CHILDREN S HOSPITAL MIAMI
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by VARIETY CHILDREN S HOSPITAL dba MIAMI CHILDREN S HOSPITAL MIAMI filed Critical VARIETY CHILDREN S HOSPITAL dba MIAMI CHILDREN S HOSPITAL MIAMI
Publication of DE602005026407D1 publication Critical patent/DE602005026407D1/de
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H1/00—Processes for the preparation of sugar derivatives
    • C07H1/06—Separation; Purification
    • C07H1/08—Separation; Purification from natural products
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
    • C08B37/0009—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid alpha-D-Glucans, e.g. polydextrose, alternan, glycogen; (alpha-1,4)(alpha-1,6)-D-Glucans; (alpha-1,3)(alpha-1,4)-D-Glucans, e.g. isolichenan or nigeran; (alpha-1,4)-D-Glucans; (alpha-1,3)-D-Glucans, e.g. pseudonigeran; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Genetics & Genomics (AREA)
  • Materials Engineering (AREA)
  • Polymers & Plastics (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE602005026407T 2004-07-09 2005-07-11 Materialien und verfahren zur stimulierung des immunsystems Active DE602005026407D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US58654804P 2004-07-09 2004-07-09
PCT/US2005/024410 WO2006010069A1 (en) 2004-07-09 2005-07-11 Materials and methods for immune system stimulation

Publications (1)

Publication Number Publication Date
DE602005026407D1 true DE602005026407D1 (de) 2011-03-31

Family

ID=34973215

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602005026407T Active DE602005026407D1 (de) 2004-07-09 2005-07-11 Materialien und verfahren zur stimulierung des immunsystems

Country Status (8)

Country Link
US (1) US7425548B2 (de)
EP (1) EP1781708B1 (de)
JP (1) JP5165372B2 (de)
AT (1) ATE498633T1 (de)
DE (1) DE602005026407D1 (de)
ES (1) ES2360862T3 (de)
IL (1) IL180612A (de)
WO (1) WO2006010069A1 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8652546B2 (en) * 2007-09-06 2014-02-18 Tahitian Noni International, Inc. Morinda citrifolia based formulations for regulating T cell immunomodulation in neonatal stock animals
US8008031B2 (en) * 2007-12-19 2011-08-30 National Pingtung University Of Science And Technology Competitive receptor binding assay for detecting beta-glucans
EP2329276A4 (de) 2008-10-01 2012-07-04 Samsung Electronics Co Ltd Mikrofluidische vorrichtung auf zentrifugalkraftbasis, verfahren zu ihrer herstellung sowie verfahren zum testen von proben mithilfe der mikrofluidischen vorrichtung
FI20080665A0 (fi) * 2008-12-18 2008-12-18 Glykos Finland Oy Luonnollisen tyyppiset sakkaridikoostumukset
JP5759445B2 (ja) 2009-03-25 2015-08-05 ザ ボード オブ リージェンツ オブ ザ ユニバーシティー オブ テキサス システム 病原体に対する哺乳類先天性免疫抵抗性の刺激のための組成物
MY179036A (en) * 2012-12-13 2020-10-26 Malaysian Palm Oil Board Anti-proliferative effects of palm vegetation liquor and extracts thereof in preventing pancreatic cancer
WO2016044839A2 (en) 2014-09-19 2016-03-24 The Board Of Regents Of The University Of Texas System Compositions and methods for treating viral infections through stimulated innate immunity in combination with antiviral compounds
KR101629656B1 (ko) * 2014-10-24 2016-06-14 충남대학교산학협력단 면역증강효과를 갖는 수용성 다당체 및 이를 함유하는 조성물
CA2994076A1 (en) 2018-02-06 2019-08-06 Brand Shared Services Llc Formwork system
BR112020026112A2 (pt) * 2018-06-21 2021-04-06 Shattuck Labs, Inc. Proteínas heterodiméricas e usos das mesmas
CN110437343A (zh) * 2019-07-16 2019-11-12 江苏农牧科技职业学院 一种香菇多糖的提取方式

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5166379A (en) * 1990-02-16 1992-11-24 Harbor Branch Oceanographic Institution, Inc. Synthesis of compounds with biological activity, and methods of use
IN184422B (de) 1993-06-01 2000-08-26 Council Scient Ind Res
IN183192B (de) 1994-01-25 1999-10-02 Council Scient Ind Res
US5529778A (en) * 1994-09-13 1996-06-25 Rohatgi; Surendra Ayurvedic composition for the prophylaxis and treatment of AIDS, flu, TB and other immuno-deficiencies and the process for preparing the same
IN179810B (de) 1996-06-20 1997-12-13 Raptakos Brett & Co Ltd
US5683698A (en) * 1996-08-02 1997-11-04 New England Deaconess Hospital Formulation for alleviating symptoms associated with arthritis
IN183487B (de) 1997-07-15 2000-01-15 Synit Drugs Pvt Ltd
IN183805B (de) 1998-01-29 2000-04-22 Bhabha Atomic Res Ct
US6451354B1 (en) * 1999-10-26 2002-09-17 Pharma Terra, Inc. Natural product composition for decreasing IgE production and treating secondary allergic responses
US20020142055A1 (en) * 2000-12-28 2002-10-03 Wockhardt Limited Treatment of immune system-modulated disorders
US20040033273A1 (en) * 2001-02-14 2004-02-19 Ayurcore, Inc. Withasol and methods of use
US6379721B1 (en) * 2001-02-15 2002-04-30 Council For Scientific And Industrial Research Process for preparation of α-amylase from Tinospora cordifolia Miers useful for starch saccharification
GB0116948D0 (en) * 2001-07-11 2001-09-05 Sahajanand Biotech Private Ltd Herbal formulation
US6582733B1 (en) * 2002-05-15 2003-06-24 Som C. Pruthi Composition for the treatment of hepatitis including HCV

Also Published As

Publication number Publication date
ATE498633T1 (de) 2011-03-15
IL180612A0 (en) 2007-06-03
US20060009501A1 (en) 2006-01-12
JP5165372B2 (ja) 2013-03-21
US7425548B2 (en) 2008-09-16
IL180612A (en) 2013-04-30
EP1781708A1 (de) 2007-05-09
ES2360862T3 (es) 2011-06-09
WO2006010069A1 (en) 2006-01-26
EP1781708B1 (de) 2011-02-16
JP2008506024A (ja) 2008-02-28

Similar Documents

Publication Publication Date Title
DE602005026407D1 (de) Materialien und verfahren zur stimulierung des immunsystems
ZA200610255B (en) Activable particles, preparations and uses
ATE314095T1 (de) Virusähnliche partikel zur induktion von autoantikörpern
TR200103018T2 (tr) İmmünostimülatör oligonükleotid ve saponin içeren katkı bileşikleri.
WO2008039874A3 (en) Cancer stem cell antigen vaccines and methods
DE60029799D1 (de) Verbindungen, verfahren und pharmazeutische zubereitungen zur behandlung von zellschäden wie zum beispiel schäden an nerven- oder kerzgefässgewebe
EP2292264A3 (de) Methoden und Zusammensetzungen zur Erhöhung der Wirksamkeit von therapeutischen Antikörper unter Verwendung von Verbindungen, die NK-Zellen potenzieren
NO20045521L (no) Diarylureaderivater anvendelige for behandling av proteinkinaseavhengige sykdommer
MX2010005244A (es) Composiciones y métodos para la terapia y el diagnóstico de influenza.
MX2009008918A (es) Activacion de celulas que presentan antigeno humano a traves de clec-6.
EA201170659A1 (ru) Антитела к рецептору ii tgf-вета
TW200606162A (en) Pyrazolopyridine derivatives
MY140840A (en) Acylated, heteroaryl-condensed cycloalkenylamines and their use as pharmaceuticals
CY1108794T1 (el) Σπειροκυκλικα παραγωγα κυκλοεξανιου
EA200700637A1 (ru) Соли донепезила, подходящие для получения фармацевтических композиций
SE0300098D0 (sv) Use of cyclin D1 inhibitors
TW200740833A (en) Boron compounds
ATE411981T1 (de) Tetrahydrocarbazolderivate und deren pharmazeutische verwendung
GB2429711A (en) Heart and skeletal muscle inflammation (HSMI) virus
MX2011002309A (es) Anticuerpos de aves especificos para virus de influenza y metodos tecnologicamente sencillos de su fabricacion y uso.
EP1556513A4 (de) Zusammensetzungen und verfahren zurbehandlung von krankheiten, die durch das humane papillomavirus vermitteltwerden
AR039186A1 (es) Celulas madre indiferenciadas programables de origen monocitaro, su obtencion y uso
BR0015597A (pt) Uso de anticorpos como vacinas
NO20060637L (no) Autologe selv-toleranse induserende celler av monocytisk opprinnelse og deres anvendelse i farmasoytiske preparater
WO2019035144A3 (en) Composition for strengthening the immune system and method of preparation thereof